Covered recipient · General Payments record
ADAM J BIHL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$567.85
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $444.43 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $234.86 | 23 |
| Janssen Pharmaceuticals, Inc | $53.89 | 2 |
| Novo Nordisk AS | $49.13 | 3 |
| Lilly USA, LLC | $30.47 | 2 |
| Inspire Medical Systems, Inc. | $17.70 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.74 | 1 |
| Exact Sciences Corporation | $14.29 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.77 | 1 |
| PFIZER INC. | $13.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.82 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326758 | CMS |
| ABBVIE INC. | $13.77 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326760 | CMS |
| ABBVIE INC. | $15.65 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326762 | CMS |
| ABBVIE INC. | $16.23 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326764 | CMS |
| ABBVIE INC. | $16.39 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326766 | CMS |
| ABBVIE INC. | $5.29 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326768 | CMS |
| ABBVIE INC. | $8.72 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326770 | CMS |
| ABBVIE INC. | $28.17 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326772 | CMS |
| ABBVIE INC. | $7.30 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326774 | CMS |
| ABBVIE INC. | $6.25 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326776 | CMS |
| ABBVIE INC. | $6.27 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326778 | CMS |
| ABBVIE INC. | $12.60 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326780 | CMS |
| ABBVIE INC. | $6.72 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326782 | CMS |
| ABBVIE INC. | $7.11 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326784 | CMS |
| ABBVIE INC. | $8.94 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326786 | CMS |
| ABBVIE INC. | $8.32 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326788 | CMS |
| ABBVIE INC. | $16.65 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326790 | CMS |
| ABBVIE INC. | $9.13 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326792 | CMS |
| ABBVIE INC. | $8.15 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326794 | CMS |
| ABBVIE INC. | $7.99 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326796 | CMS |
| ABBVIE INC. | $5.12 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326798 | CMS |
| ABBVIE INC. | $7.21 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326800 | CMS |
| ABBVIE INC. | $8.06 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103326802 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.77 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086159780 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.74 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117897952 | CMS |
| Exact Sciences Corporation | $14.29 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114592634 | CMS |
| Inspire Medical Systems, Inc. | $17.70 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148043424 | CMS |
| Janssen Pharmaceuticals, Inc | $20.84 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078132677 | CMS |
| Janssen Pharmaceuticals, Inc | $33.05 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078132657 | CMS |
| Lilly USA, LLC | $15.38 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136010459 | CMS |
| Lilly USA, LLC | $15.09 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136006333 | CMS |
| Novo Nordisk Inc | $14.27 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097243706 | CMS |
| Novo Nordisk Inc | $19.78 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097101407 | CMS |
| Novo Nordisk Inc | $15.08 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096713847 | CMS |
| PFIZER INC. | $13.58 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131380269 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.